These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25907232)

  • 41. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance.
    Li JJ; Dou KF; Zhou ZG; Zhao D; Ye P; Chen H; Chen ZY; Peng DQ; Guo YL; Wu NQ; Qian J;
    Clin Pharmacol Ther; 2024 May; 115(5):954-964. PubMed ID: 38459425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addressing statin adverse effects in the clinic: the 5 Ms.
    Katz DH; Intwala SS; Stone NJ
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An assessment by the Statin Muscle Safety Task Force: 2014 update.
    Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Statin myopathy--rarity or reality?].
    Pella D
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Statin intolerance and statin-associated muscular pain].
    Stürzebecher PE; Schumann F; Kassner U; Laufs U
    Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decoding the Intricacies of Statin-Associated Muscle Symptoms.
    Rastegar TF; Khan IA; Christopher-Stine L
    Curr Rheumatol Rep; 2024 Jul; 26(7):260-268. PubMed ID: 38575845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Statin intolerance and associated muscular dysfunctions].
    Boulanger-Piette A; Bergeron J; Desgreniers J; Côté-Levesque M; Brassard D; Joanisse DR; Frenette J
    Med Sci (Paris); 2015 Dec; 31(12):1109-14. PubMed ID: 26672664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the management of statin myopathy.
    Gallo A; Perregaux J; Bruckert E
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
    Sahebkar A; Saboni N; Pirro M; Banach M
    J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report.
    Okeahialam BN
    Vasc Health Risk Manag; 2015; 11():579-81. PubMed ID: 26604775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Statin-induced adverse effects -- facts and genes].
    Harangi M; Zsíros N; Juhász L; Paragh G
    Orv Hetil; 2013 Jan; 154(3):83-92. PubMed ID: 23315223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
    Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
    Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis.
    Irwin JC; Khalesi S; Fenning AS; Vella RK
    Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin Intolerance: the Clinician's Perspective.
    Stulc T; Ceška R; Gotto AM
    Curr Atheroscler Rep; 2015 Dec; 17(12):69. PubMed ID: 26490078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview of statin-induced myopathy and perspectives for the future.
    Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
    Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.